1. Home
  2. PLSE vs IHS Comparison

PLSE vs IHS Comparison

Compare PLSE & IHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLSE
  • IHS
  • Stock Information
  • Founded
  • PLSE 2014
  • IHS 2001
  • Country
  • PLSE United States
  • IHS United Kingdom
  • Employees
  • PLSE N/A
  • IHS N/A
  • Industry
  • PLSE Medical/Dental Instruments
  • IHS Telecommunications Equipment
  • Sector
  • PLSE Health Care
  • IHS Telecommunications
  • Exchange
  • PLSE Nasdaq
  • IHS Nasdaq
  • Market Cap
  • PLSE 1.1B
  • IHS 996.3M
  • IPO Year
  • PLSE 2016
  • IHS 2021
  • Fundamental
  • Price
  • PLSE $17.79
  • IHS $3.17
  • Analyst Decision
  • PLSE
  • IHS Strong Buy
  • Analyst Count
  • PLSE 0
  • IHS 6
  • Target Price
  • PLSE N/A
  • IHS $9.42
  • AVG Volume (30 Days)
  • PLSE 168.8K
  • IHS 447.5K
  • Earning Date
  • PLSE 10-30-2024
  • IHS 11-12-2024
  • Dividend Yield
  • PLSE N/A
  • IHS N/A
  • EPS Growth
  • PLSE N/A
  • IHS N/A
  • EPS
  • PLSE N/A
  • IHS N/A
  • Revenue
  • PLSE N/A
  • IHS $1,783,187,000.00
  • Revenue This Year
  • PLSE N/A
  • IHS N/A
  • Revenue Next Year
  • PLSE N/A
  • IHS $1.75
  • P/E Ratio
  • PLSE N/A
  • IHS N/A
  • Revenue Growth
  • PLSE N/A
  • IHS N/A
  • 52 Week Low
  • PLSE $6.60
  • IHS $2.18
  • 52 Week High
  • PLSE $22.69
  • IHS $4.52
  • Technical
  • Relative Strength Index (RSI)
  • PLSE 48.18
  • IHS 53.84
  • Support Level
  • PLSE $16.97
  • IHS $2.91
  • Resistance Level
  • PLSE $18.48
  • IHS $3.29
  • Average True Range (ATR)
  • PLSE 1.30
  • IHS 0.14
  • MACD
  • PLSE -0.10
  • IHS -0.03
  • Stochastic Oscillator
  • PLSE 27.68
  • IHS 61.50

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

About IHS IHS Holding Limited

IHS Holding Ltd is an independent owner, operator, and developer of shared telecommunications infrastructure. The company provides telecommunications infrastructure to its customers, most of who are MNOs, who in turn provide wireless voice and data services to their end-users. Its geographical segments are Nigeria, Sub-Saharan Africa, Middle East and North Africa (MENA), and Latin America (Latam). The majority of its revenue is derived from Nigeria.

Share on Social Networks: